September 17th 2024
Radiomics models offered a pooled AUC of 86 percent for differentiating between ruptured and unruptured intracranial aneurysms, according to a recently published meta-analysis.
SPECT Imaging Agent Gets Expanded FDA Approval for Patients with Suspected Dementia with Lewy Bodies
November 16th 2022GE Healthcare’s DaTscan is reportedly the first radiopharmaceutical tracer agent approved by the Food and Drug Administration (FDA) for use in patients with suspected dementia with Lewy bodies.
Emergency Department Radiology: Study Shows Higher Imaging Orders by NPPs
November 11th 2022A new study of nearly 17 million emergency department (ED) visits by Medicare beneficiaries between 2005 and 2020 revealed the presence of non-physician practitioners (NPPs) was associated with a 5.3 percent increase in imaging.
Recognizing the Role of Enterprise Imaging in Handling and Protecting Sensitive Patient Information
October 19th 2022While facilitating interdisciplinary colloaboration is a central objective with enterprise imaging platforms, this author says implementation of these platforms must ensure optimal patient privacy in sensitive cases involving abuse, assault and domestic violence.
GE Healthcare Launches Omni Legend PET/CT System at EANM Congress
October 17th 2022The inclusion of digital bismuth germanate (BGO) detector material with the Omni Legend system reportedly more than doubles the sensitivity of older PET/CT devices, improves scan times, and enhances the detection of small lesions.
GE Healthcare Announces Moves to Bolster Supply of Iodinated Contrast Media for CT and X-Ray Imaging
October 14th 2022A multi-year agreement with a large Chile-based supplier of raw iodine is part of GE Healthcare’s commitment to increase the production of iodinated contrast media, commonly used in computed tomography imaging, by 30 million annually in 2025.
Managing Incidentalomas in Radiology: Embracing Challenges as Opportunities
September 12th 2022Greater imaging utilization has increased the prevalence of incidental findings or incidentalomas, but unclear clinical context and guidelines complicate management. Accordingly, these authors offer a thorough review of the literature and discuss new opportunities for improving interdisciplinary management strategies.
Is CT Imaging Overutilized in the ER?
August 30th 2022Emerging research findings suggest the use of single-encounter thoraco-abdominopelvic computed tomography (CT) per 1,000 trauma-related emergency department (ED) visits more than quadrupled for minor injuries and more than doubled for intermediate injuries from 2011 to 2018.
Study Suggests AI Enhances Non-Contrast CT Detection of Large Vessel Occlusion
July 29th 2022Artificial intelligence (AI) accurately diagnosed 79 percent of proximal large vessel occlusions with an ipsiversive gaze deviation on non-contrast computed tomography (CT), according to new research findings presented recently at the Society of Neurointerventional Surgery’s (SNIS) 19th Annual Meeting in Toronto.
Iodinated Contrast Media Alternative: FDA OKs Bayer Importing Foreign-Labeled Iopromide
July 19th 2022The Food and Drug Administration (FDA) has given the green light to Bayer to import foreign-labeled iopromide (Ultravist) to help alleviate ongoing supply challenges with iodinated contrast media in the United States.
Is Whole Body Imaging Warranted for Thrombocytopenia Caused by a COVID-19 Vaccine?
June 14th 2022In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.
Siemens Healthineers Get FDA Nod for New SPECT/CT Scanner
June 12th 2022The newly FDA-cleared Symbia Pro.specta SPECT/CT Scanner, which reportedly offers a variety of enhanced capabilities including low-dose CT up to 64 slices and intuitive workflow guides, was launched at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting.